Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Title: Genome-Wide Association Study of Endometrial Cancer in E2C2      
citations:
19132539
24096698
24810602
description:
Endometrial cancer, the most common gynecological malignancy in the United States, has both an environmental and genetic component. To this end, we conducted a genome-wide association study to identify genes involved in endometrial cancer using studies from the NCI-supported Epidemiology of Endometrial Cancer Consortium (E2C2). For the discovery stage we included samples from 6 cohort and 7 case control studies through 2007. The total number of cases genotyped were 2,307, white women of European descent, and 2,307 matched controls using the Illumina HumanOmniExpress platform. We conducted the replication using the Infinium HumanExome BeadChip, which successfully genotyped 177,139 variants in 1055 cases and 1778 controls from four ethnically diverse studies that are part of the Epidemiology of Endometrial Cancer Consortium (E2C2). The overall goal is to determine whether certain genotypes are predictive of future endometrial cancer risk, and whether the genotypes interact with established endometrial risk factors.
Identifier:
phs000893.v1.p1
accesstypes:
download
enclave
landingpage: http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000893.v1.p1
authentication: simpleLogin
none
authorization:
none
duaIndividual
name:
Carcinoma, Endometrioid
Endometrial Neoplasms
Uterine Neoplasms
affiliations:
Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA and Harvard TH Chan School of Public Health, Boston, MA, USA
name:
Immaculata De Vivo, PhD
roles:
Principal Investigator
affiliations:
National Cancer Institute, National Health Institute, Bethesda, MD, USA
name:
R01 CA134958-01A1
roles:
Funding Source
performedBy:
TitleNameInstitute Principal InvestigatorImmaculata De Vivo, PhDBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA and Harvard TH Chan School of Public Health, Boston, MA, USA Funding SourceR01 CA134958-01A1National Cancer Institute, National Health Institute, Bethesda, MD, USA
downloadURL: https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&view_pdf&stacc=phs000893.v1.p1
Identifier:
phs000893.v1.p1_policy
name:
Data Use Certificate
Identifier:
1
name:
General Research Use (MDS)
Identifier:
2
name:
General Research Use (COL, MDS)
Identifier:
3
name:
Disease-Specific (Cancer)
Identifier:
4
name:
Disease-Specific (Endometrial Carcinoma, MDS)
Identifier:
5
name:
Disease-Specific (Endometrial Diseases, MDS)
Identifier:
6
name:
Disease-Specific (Breast, Ovarian, or Endometrial Disease, MDS)
Identifier:
7
name:
Disease-Specific (Chronic Diseases)
Identifier:
8
name:
Cancer in all age groups, other disease in adults only and methods
Identifier:
9
name:
Health/Medical/Biomedical (PUB, NPU, MDS, GSO)
alternateIdentifiers:
yes
selectionCriteria: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898362/bin/439_2013_1369_MOESM1_ESM.docx

">

Cases included women who were newly diagnosed with endometrial cancer. Controls from nested case-control studies were cancer free at the time of case diagnosis. Controls from case-control studies must have had an intact uterus (i.e. no hysterectomies). All subjects must have provided biospecimens. Subject IDs whose genotyping did not pass quality control were excluded.

Detailed inclusion/exclusion criteria can be found at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898362/bin/439_2013_1369_MOESM1_ESM.docx

dateReleased:
03-27-2015
version:
phs000893.v1.p1
dateModified:
03-27-2015
abbreviation:
NCI
name:
NCI
ID:
0
name:
dbGaP

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on GitHub.